{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:59:36Z","timestamp":1771984776060,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejpn.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T03:53:02Z","timestamp":1663645982000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0215-1043","authenticated-orcid":false,"given":"Mira\u00e7","family":"Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-7818","authenticated-orcid":false,"given":"\u0130brahim","family":"\u00d6ncel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2514-8461","authenticated-orcid":false,"given":"\u00d6mer","family":"Bekta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-4398","authenticated-orcid":false,"given":"Gizem","family":"Tanal\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-5826","authenticated-orcid":false,"given":"S\u00fcleyman","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1918-4407","authenticated-orcid":false,"given":"Tezer","family":"Kutluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-2912","authenticated-orcid":false,"given":"Serap","family":"Teber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-6229","authenticated-orcid":false,"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2022.09.002_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.25.3.271","article-title":"Myoclonic encephalopathy of infants","volume":"25","author":"Kinsbourne","year":"1962","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejpn.2022.09.002_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/jnp.2006.18.2.239","article-title":"Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia","volume":"18","author":"Turkel","year":"2006","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejpn.2022.09.002_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejpn.2009.03.002","article-title":"A\u00a0prospective study of the presentation and management of dancing eye syndrome\/opsoclonus-myoclonus syndrome in the United Kingdom","volume":"14","author":"Pang","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/practneurol-2011-000017","article-title":"The opsoclonus\u2013myoclonus syndrome","volume":"11","author":"Sahu","year":"2011","journal-title":"Practical Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3389\/fneur.2017.00468","article-title":"Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study","volume":"8","author":"Pranzatelli","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.braindev.2014.10.010","article-title":"A\u00a0nationwide survey of opsoclonus-myoclonus syndrome in Japanese children","volume":"37","author":"Hasegawa","year":"2015","journal-title":"Brain Dev."},{"key":"10.1016\/j.ejpn.2022.09.002_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.braindev.2015.11.007","article-title":"Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome","volume":"38","author":"Pranzatelli","year":"2016","journal-title":"Brain Dev."},{"key":"10.1016\/j.ejpn.2022.09.002_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2352-4642(17)30130-X","article-title":"Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial","volume":"2","author":"de Alarcon","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ejpn.2022.09.002_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/MOP.0b013e32833fde3f","article-title":"Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome","volume":"22","author":"Gorman","year":"2010","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.ejpn.2022.09.002_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejpn.2009.12.005","article-title":"Opsoclonus-myoclonus in children associated or not with neuroblastoma","volume":"14","author":"Krug","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/0883073820911327","article-title":"Infection-associated opsoclonus: a retrospective case record analysis and review of literature","volume":"35","author":"Saini","year":"2020","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14737175.2016.1176914","article-title":"Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment","volume":"16","author":"Blaes","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejpn.2022.09.002_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2017.04.027","article-title":"Dexamethasone, intravenous immunoglobulin, and rituximab combination immunotherapy for pediatric opsoclonus-myoclonus syndrome","volume":"73","author":"Pranzatelli","year":"2017","journal-title":"Pediatr. Neurol."},{"issue":"228","key":"10.1016\/j.ejpn.2022.09.002_bib14","first-page":"275","article-title":"Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy","volume":"2005","author":"Matthay","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejpn.2022.09.002_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/B978-0-444-52910-7.00042-8","article-title":"Opsoclonus-myoclonus syndrome","volume":"112","author":"Pike","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.braindev.2017.05.001","article-title":"Childhood opsoclonus-myoclonus syndrome: a case series from Tunisia","volume":"39","author":"Ben Achour","year":"2017","journal-title":"Brain Dev."},{"key":"10.1016\/j.ejpn.2022.09.002_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.744041","article-title":"Clinical analysis of pediatric opsoclonus-myoclonus syndrome in one of the national children's medical center in China","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2017.03.011","article-title":"Opsoclonus-myoclonus syndrome: a New era of improved prognosis?","volume":"72","author":"Galstyan","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/adc.68.6.771","article-title":"Determinants of symptom interval in childhood cancer","volume":"68","author":"Saha","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejpn.2022.09.002_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/pho.21.1.37.48","article-title":"Delay in diagnosis of children with cancer: a retrospective study of 315 children","volume":"21","author":"Haimi","year":"2004","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib21","article-title":"Clinical features of children with retinoblastoma and neuroblastoma","volume":"2020","author":"Fang","year":"2020","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.ejpn.2022.09.002_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MPH.0b013e3181a6dea4","article-title":"Neuroblastoma in Turkish children: experience of a single center","volume":"31","author":"Ayd\u0131n","year":"2009","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.109.1.86","article-title":"Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae","volume":"109","author":"Mitchell","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2022.09.002_bib24","first-page":"225","article-title":"Neuroblastoma: paradigm for precision medicine","volume":"62","author":"Irwin","year":"2015","journal-title":"Pediatr. Clin."},{"key":"10.1016\/j.ejpn.2022.09.002_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0887-8994(92)90060-C","article-title":"Opsoclonus-myoclonus with Beckwith-Wiedemann syndrome and hepatoblastoma","volume":"8","author":"Wilfong","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.bmt.1705153","article-title":"Opsoclonus myoclonus following allogeneic haematopoietic stem cell transplantation","volume":"36","author":"Bishton","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ejpn.2022.09.002_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/B978-0-444-51892-7.00012-7","article-title":"Toxic agents causing cerebellar ataxias","volume":"103","author":"Manto","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/B978-0-444-53502-3.00031-8","article-title":"Neurological complications of chemotherapy to the central nervous system","volume":"105","author":"Newton","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib29","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1212\/NXI.0000000000001153","article-title":"Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective","volume":"9","author":"Rossor","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejpn.2022.09.002_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0972-2327.70876","article-title":"Opsoclonus-myoclonus syndrome caused by varicella-zoster virus","volume":"13","author":"Singh","year":"2010","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.33588\/rn.4108.2004616","article-title":"Parainfectious opsoclonus-myoclonus syndrome secondary to varicella-zoster virus infection","volume":"41","author":"Medrano","year":"2005","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pediatrneurol.2010.02.009","article-title":"Opsoclonus-myoclonus syndrome attributable to hepatitis C infection","volume":"42","author":"Ertekin","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2015.07.007","article-title":"Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome","volume":"286","author":"Panzer","year":"2015","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","article-title":"Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies","volume":"73","author":"Armangu\u00e9","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib35","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","article-title":"Adult-onset opsoclonus-myoclonus syndrome","volume":"69","author":"Klaas","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.clineuro.2009.03.010","article-title":"False positive autoantibodies to glutamic acid decarboxylase in opsoclonus-myoclonus-ataxia syndrome after intravenous treatment with immunoglobulin","volume":"111","author":"de Beer","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ejpn.2022.09.002_bib38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/rg.2018170132","article-title":"Updates in diagnosis, management, and treatment of neuroblastoma","volume":"38","author":"Swift","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.ejpn.2022.09.002_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2018.04.007","article-title":"Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS","volume":"321","author":"Pranzatelli","year":"2018","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2011.02.012","article-title":"Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus","volume":"45","author":"Pranzatelli","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/adc.2010.204792","article-title":"Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome","volume":"97","author":"Brunklaus","year":"2012","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejpn.2022.09.002_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","article-title":"Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome","volume":"28","author":"Pranzatelli","year":"2006","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":"Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2022.09.002_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0883073812471433","article-title":"Clinical profile and outcome of children with opsoclonus-myoclonus syndrome","volume":"29","author":"Singhi","year":"2014","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ejpn.2022.09.002_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1043454204272560","article-title":"Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome","volume":"22","author":"Tate","year":"2005","journal-title":"J.\u00a0Pediatr. Oncol. Nurs."},{"key":"10.1016\/j.ejpn.2022.09.002_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0029-1237723","article-title":"Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome","volume":"40","author":"De Grandis","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2022.09.002_bib47","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1542\/peds.2010-3114","article-title":"Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life","volume":"128","author":"Brunklaus","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2022.09.002_bib48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0033-1358604","article-title":"Update on pediatric opsoclonus myoclonus syndrome","volume":"44","author":"Hero","year":"2013","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ejpn.2022.09.002_bib49","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/0883073814549581","article-title":"Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS)","volume":"30","author":"Mitchell","year":"2015","journal-title":"J.\u00a0Child Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379822001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379822001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:39:29Z","timestamp":1761071969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379822001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":49,"alternative-id":["S1090379822001374"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.09.002","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}